Literature DB >> 9815251

Interferon-gamma and interleukin-4 responses in relation to serum IgE levels in persons infected with human T lymphotropic virus type I and Strongyloides stercoralis.

F A Neva1, J O Filho, A A Gam, R Thompson, V Freitas, A Melo, E M Carvalho.   

Abstract

Possible immunologic interaction between infection with human T lymphotropic virus type 1 (HTLV-1), a retrovirus, and the intestinal parasite Strongyloides stercoralis was investigated in persons infected with one or both agents. This was done by examining the cytokine responses of peripheral blood mononuclear cells (PBMC) to mitogens and Strongyloides antigen. PBMC of subjects infected with HTLV-1 spontaneously produced interferon (IFN)-gamma with levels that correlated inversely with serum IgE levels. HTLV-1-infected subjects also had poor interleukin (IL)-4 responses to mitogenic stimulation, unlike persons without HTLV-1 infection. It is postulated that the IFN-gamma produced by activated T cells in some HTLV-1-infected persons acts to down-regulate IL-4 with consequent reduction of serum IgE levels. The impaired IgE responses and other effects of IL-4 down-regulation may be contributing factors to more severe disease and impaired response to treatment of strongyloidiasis in some HTLV-1-infected persons.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9815251     DOI: 10.1086/314507

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  25 in total

1.  Human T-cell lymphotropic virus Type I association with Strongyloïdes stercoralis: a case control study among Caribbean blood donors from Guadeloupe (French West Indies).

Authors:  G Courouble; F Rouet; C Hermann-Storck; M Nicolas; E Candolfi; M Strobel; B Carme
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

2.  Levels of serum chemokines discriminate clinical myelopathy associated with human T lymphotropic virus type 1 (HTLV-1)/tropical spastic paraparesis (HAM/TSP) disease from HTLV-1 carrier state.

Authors:  J B Guerreiro; S B Santos; D J Morgan; A F Porto; A L Muniz; J L Ho; A L Teixeira; M M Teixeira; E M Carvalho
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

Review 3.  The immunology of parasite infections in immunocompromised hosts.

Authors:  T Evering; L M Weiss
Journal:  Parasite Immunol       Date:  2006-11       Impact factor: 2.280

Review 4.  Innate and adaptive immunity to the nematode Strongyloides stercoralis in a mouse model.

Authors:  Sandra Bonne-Année; Jessica A Hess; David Abraham
Journal:  Immunol Res       Date:  2011-12       Impact factor: 2.829

5.  A retrospective study of autochthonous strongyloïdiasis in Région Midi-Pyrénées (Southwestern France).

Authors:  J F Magnaval; J M Mansuy; L Villeneuve; S Cassaing
Journal:  Eur J Epidemiol       Date:  2000-02       Impact factor: 8.082

6.  Alcoholism and Strongyloides stercoralis: daily ethanol ingestion has a positive correlation with the frequency of Strongyloides larvae in the stools.

Authors:  Carla Couzi Marques; Maria da Penha Zago-Gomes; Carlos Sandoval Gonçalves; Fausto Edmundo Lima Pereira
Journal:  PLoS Negl Trop Dis       Date:  2010-06-22

7.  HTLV-1 modifies the clinical and immunological response to schistosomiasis.

Authors:  A F Porto; S B Santos; L Alcantara; J B Guerreiro; J Passos; T Gonzalez; F Neva; D Gonzalez; J L Ho; E M Carvalho
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

Review 8.  Strongyloides stercoralis in the Immunocompromised Population.

Authors:  Paul B Keiser; Thomas B Nutman
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

Review 9.  Human infection with Strongyloides stercoralis and other related Strongyloides species.

Authors:  Thomas B Nutman
Journal:  Parasitology       Date:  2016-05-16       Impact factor: 3.234

10.  IgG1, IgG4, and IgE antibody responses in human strongyloidiasis by ELISA using Strongyloides ratti saline extract as heterologous antigen.

Authors:  Rosângela M Rodrigues; Maria C de Oliveira; Mônica C Sopelete; Deise A O Silva; Dulcinéa M B Campos; Ernesto A Taketomi; Julia M Costa-Cruz
Journal:  Parasitol Res       Date:  2007-07-04       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.